News Daily News AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons L.A. McKeown September 20, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets Michael O'Riordan September 14, 2023
News Conference News ESC 2023 ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran Michael O'Riordan September 01, 2023
News Daily News ESC 2023 Dietary Nitrate Dramatically Cuts Contrast-Induced Nephropathy: NITRATE-CIN Michael O'Riordan August 30, 2023
News Daily News Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE Michael O'Riordan July 25, 2023
News Daily News Keto Diet for Heart Failure? What Clinicians, Patients Need to Know Caitlin E. Cox July 06, 2023
News Conference News ESC Heart Failure 2023 Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues Shelley Wood May 25, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Daily News In COVID-19 Patients, Vaccination Linked to Lower MACE Risk Michael O'Riordan February 22, 2023
News Daily News Autism and Cardiometabolic Disease Often Go Hand in Hand Caitlin E. Cox February 06, 2023
News Daily News Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3 Michael O'Riordan January 16, 2023
News Daily News Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS Michael O'Riordan December 30, 2022
News Daily News Slight Risk of Interstitial Lung Disease Seen With Certain DOACs Todd Neale November 23, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Conference News AHA 2022 ‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE Michael O'Riordan November 06, 2022
News Conference News AHA 2022 CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis Yael L. Maxwell November 05, 2022